Effect of rifampicin administration on CYP induction in a dermatomyositis patient with vasospastic angina attributable to nilmatrelvir/ritonavir-induced blood tacrolimus elevation: A case report-Reference-Cited by-同舟云学术

Effect of rifampicin administration on CYP induction in a dermatomyositis patient with vasospastic angina attributable to nilmatrelvir/ritonavir-induced blood tacrolimus elevation: A case report

Published:2024-09 Issue:9 Volume:30 Page:928-933
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Akamatsu Hayato^ORCID,Kohno Yusuke,Hashizume Junya,Nakagawa Hiroo,Kodama Yukinobu,Kawano Hiroaki^ORCID,Maemura Koji^ORCID,Ohyama Kaname

Publisher

Elsevier BV

Reference30 articles.

1. Innovative randomized phase I study and dosing regimen selection to accelerate and inform pivotal COVID-19 trial of nirmatrelvir;Singh;Clin Pharmacol Ther,2022

2. Paxlovid (Nirmatelvir/Ritonavir) and tacrolimus drug-drug interaction in a kidney transplant patient with SARS-2-CoV infection: a case report;Prikis;Transplant Proc,2022

3. Case report: nirmatrelvir/ritonavir and tacrolimus in a kidney transplant recipient with COVID-19;Lindauer;Am Fam Physician,2022

4. Paxlovid-tacrolimus drug-drug interaction in a 23-year-old female kidney transplant patient with COVID-19;Berar Yanay;Clin Drug Invest,2022

5. Nirmatrelvir/ritonavir-induced elevation of blood tacrolimus levels in a patient in the maintenance phase post liver transplantation;Shiohira;J Infect Chemother,2024

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report and literature review: management of Paxlovid (nirmatrelvir/ritonavir)-induced acute tacrolimus toxicity in a patient with systemic lupus erythematosus;Frontiers in Pharmacology;2024-06-19

2. Multiple drugs;Reactions Weekly;2024-04-06